Drugs Affecting Blood and Blood Formation Practice Questions

Q: Urgent reversal of warfarin-induced bleeding can be achieved by the administration of which of the following?

Fresh frozen plasma. **Explanation:** Warfarin exerts its anticoagulant effect by inhibiting the enzyme **Vitamin K Epoxide Reductase (VKOR)**, which prevents the gamma-carboxylation (activation) of clotting factors **II, VII, IX, and X**. In cases of life-threatening bleeding or urgent surgery, the goal is to immediately replace these functional clotting factors. **Why Fresh Frozen Plasma (FFP) is correct:** FFP contains all the coagulation factors in their active forms. It is the standard treatment for the rapid reversal of warfarin because it provides an immediate source of the Vitamin K-dependent factors that the patient’s liver cannot currently produce. While **Prothrombin Complex Concentrate (PCC)** is technically the first-line treatment in modern guidelines due to faster action and lower volume, FFP remains the classic and correct choice among the provided options. **Why the other options are incorrect:** * **A. Cryoprecipitate:** This is rich in Factor VIII, von Willebrand factor, and Fibrinogen. It does not contain sufficient amounts of the Vitamin K-dependent factors (II, VII, IX, X) required for warfarin reversal. * **B. Platelet concentrates:** Warfarin affects the coagulation cascade (humoral immunity), not platelet count or function. * **D. Packed red blood cells:** These are used to restore oxygen-carrying capacity in anemia or hemorrhage but do not contain clotting factors. **High-Yield NEET-PG Pearls:** * **Antidote for Warfarin:** Vitamin K (Phytonadione) is used for non-urgent reversal, but it takes 6–24 hours to work as it requires new protein synthesis. * **Immediate Reversal:** PCC (Prothrombin Complex Concentrate) > FFP. * **Monitoring:** Warfarin is monitored using **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes Fetal Warfarin Syndrome); Heparin is the preferred anticoagulant for pregnant women.

Q: What is the dose of vitamin K in cases of serious bleeding?

10 mg. **Explanation:** The management of Warfarin-induced bleeding is a high-yield topic for NEET-PG. The correct dose of Vitamin K (Phytonadione) depends on the severity of the bleeding and the International Normalized Ratio (INR) levels. **Why 10 mg is correct:** In cases of **serious or life-threatening bleeding** (regardless of the INR), the standard protocol involves the rapid reversal of anticoagulation. The recommended dose is **10 mg of Vitamin K1**, administered via **slow intravenous infusion**. Because Vitamin K takes 6–12 hours to synthesize new clotting factors, it must be supplemented with immediate replacement factors like **Prothrombin Complex Concentrate (PCC)** or Fresh Frozen Plasma (FFP) in emergency scenarios. **Analysis of incorrect options:** * **A (2.5 mg) & B (5 mg):** These lower doses are typically used for **asymptomatic patients** with significantly elevated INR (usually >9) but no active bleeding. In these cases, oral administration is preferred over IV. * **D (20 mg):** Doses exceeding 10 mg are generally avoided. Higher doses do not provide faster reversal and can lead to "Warfarin resistance" for several days, making it difficult to re-anticoagulate the patient once the bleeding is controlled. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** In serious bleeding, IV is preferred. However, IV Vitamin K carries a small risk of **anaphylactoid reactions**; hence, it must be infused slowly. * **Oral vs. SC:** Oral Vitamin K is highly effective for non-emergency reversal. **Subcutaneous (SC) administration is avoided** because it is unpredictable and less effective than oral or IV routes. * **Mechanism:** Vitamin K acts as a cofactor for the enzyme **gamma-glutamyl carboxylase**, which activates Factors II, VII, IX, and X.

Q: Epogen can be given in which of the following conditions?

Anemia of chronic renal failure. **Explanation:**1. Why Option A is Correct: **Epogen (Epoetin alfa)** is a recombinant human erythropoietin (rhEPO) [1, 2, 3]. Erythropoietin is a glycoprotein hormone primarily produced by the peritubular interstitial cells of the kidney [1, 2, 3]. In **Chronic Renal Failure (CRF)**, the kidneys fail to produce sufficient erythropoietin, leading to normocytic, normochromic anemia [1, 2, 3]. Epogen acts as replacement therapy, stimulating the bone marrow to produce red blood cells, making it the treatment of choice for anemia in CRF patients [1, 3].2. Why Other Options are Incorrect:* **B. Aplastic Anemia:** This involves a primary bone marrow failure where the "factory" itself is damaged. While EPO levels are usually already high in these patients, the marrow cannot respond to it. Treatment typically requires immunosuppressants or bone marrow transplant.* **C. Hemolytic Anemia:** This is caused by the premature destruction of RBCs. The kidneys are functional and endogenous EPO levels are already maximally elevated to compensate; adding exogenous Epogen provides no benefit.* **D. Anemia of Chronic Disease (ACD):** While EPO can sometimes be used in specific cases (like cancer-related anemia), the primary pathology in ACD is iron sequestration due to high **hepcidin** levels. The first-line management is treating the underlying inflammatory condition.High-Yield NEET-PG Pearls:* **Target Hb:** When using Epogen, the target Hemoglobin should not exceed **11–12 g/dL**. Exceeding this increases the risk of hypertension, stroke, and tumor progression [1].* **Side Effects:** The most common side effect is **hypertension** and encephalopathy. It can also cause pure red cell aplasia (PRCA) due to antibody formation.* **Requirement:** For Epogen to be effective, the patient must have adequate **iron, B12, and folate stores**.* **Other Indications:** Anemia due to HIV (Zidovudine therapy) and chemotherapy-induced anemia.

Q: A 72-year-old woman with atrial fibrillation is on warfarin and is scheduled for ventral hernia repair. She was advised to stop warfarin several days before surgery and was hospitalized for heparinization. During her hospital stay, she developed severe abdominal and flank pain. Her prothrombin time (PT) is normal, but her activated partial thromboplastin time (aPTT) is elevated. An abdominal CT scan revealed a large retroperitoneal hematoma. Which of the following should be administered to reverse the effects of heparin?

Protamine sulfate. **Explanation:** The patient is experiencing a **retroperitoneal hematoma**, a known complication of heparin therapy. Heparin acts by binding to antithrombin III, which inactivates thrombin and Factor Xa. The clinical scenario shows an elevated aPTT (which monitors the intrinsic pathway affected by heparin) and a normal PT (indicating warfarin has been successfully cleared). **1. Why Protamine Sulfate is correct:** Protamine sulfate is the specific antidote for heparin. It is a highly alkaline (positive charge) protein that binds to the strongly acidic (negative charge) heparin molecule to form a stable, inactive **salt complex** through ionic bonding. This neutralization occurs rapidly. * **Dosing:** 1 mg of protamine neutralizes approximately 100 units of heparin. **2. Why other options are incorrect:** * **Thrombin (Option A):** This is a topical hemostatic agent used for surface bleeding; it cannot be used systemically to reverse heparin. * **Vitamin K (Option B):** This is the reversal agent for **Warfarin**. It acts by promoting the hepatic synthesis of Factors II, VII, IX, and X. It has no effect on heparin and takes hours to work. * **Aprotinin (Option D):** An antifibrinolytic agent (plasmin inhibitor) formerly used to reduce bleeding in cardiac surgery, but it does not neutralize heparin. **Clinical Pearls for NEET-PG:** * **Monitoring:** Heparin is monitored by **aPTT**, while Warfarin is monitored by **PT/INR**. * **LMWH Reversal:** Protamine only partially reverses Low Molecular Weight Heparin (LMWH) (approx. 60-75%). * **Side Effect:** Rapid administration of protamine can cause **hypotension**, bradycardia, and anaphylaxis (especially in patients with fish allergies or those using NPH insulin). * **Half-life:** Heparin has a short half-life (approx. 60-90 mins); if bleeding is minor, simply stopping the infusion may suffice. In this case, the hematoma necessitates active reversal.

Q: Abciximab is:

Antibody against IIb/IIIa receptors. **Explanation:** **Abciximab** is a potent antiplatelet agent classified as a **Glycoprotein (GP) IIb/IIIa receptor antagonist**. 1. **Why Option A is Correct:** Abciximab is the Fab fragment of a chimeric human-murine monoclonal antibody. It binds irreversibly to the GP IIb/IIIa receptors on the surface of activated platelets. Since these receptors are the "final common pathway" for platelet aggregation (by binding fibrinogen to cross-link platelets), inhibiting them prevents thrombus formation regardless of the initial stimulus (ADP, Thromboxane A2, or Thrombin). 2. **Why Other Options are Incorrect:** * **Option B:** Receptors Ib/IX are involved in platelet *adhesion* to von Willebrand factor (vWF), not aggregation. No major clinical drug currently targets this specifically in this manner. * **Option C:** Topoisomerase inhibitors (e.g., Etoposide, Irinotecan) are cytotoxic chemotherapy agents used in cancer treatment, not cardiovascular medicine. * **Option D:** Adenosine inhibitors (like Theophylline) or Adenosine uptake inhibitors (like Dipyridamole) have different mechanisms. Dipyridamole is an antiplatelet drug, but it works via PDE inhibition, not as an antibody. **NEET-PG High-Yield Pearls:** * **Route:** Administered only via **Intravenous (IV)** route. * **Clinical Use:** Primarily used in **Percutaneous Coronary Intervention (PCI)** to prevent ischemic complications and in Unstable Angina/NSTEMI. * **Other GP IIb/IIIa Inhibitors:** **Eptifibatide** (cyclic peptide) and **Tirofiban** (non-peptide small molecule). Unlike Abciximab, these are reversible inhibitors. * **Major Side Effect:** Bleeding and **Thrombocytopenia** (monitor platelet counts).

Q: Which of the following substances can be used as an antidote to fibrinolytics?

Epsilon amino caproic acid. ### Explanation **Correct Option: A. Epsilon amino caproic acid (EACA)** Fibrinolytics (like Streptokinase or Alteplase) work by converting plasminogen into **plasmin**, an enzyme that degrades fibrin clots. Excessive plasmin activity can lead to severe systemic bleeding. **Epsilon amino caproic acid (EACA)** and **Tranexamic acid** act as antifibrinolytics by competitively inhibiting plasminogen activation and binding to fibrin. They occupy the lysine-binding sites on plasminogen/plasmin, preventing it from binding to and degrading fibrin, thereby stabilizing the clot and reversing the effect of fibrinolytics. **Analysis of Incorrect Options:** * **B. Protamine:** This is the specific antidote for **Heparin** overdose. It is a strongly basic protein that neutralizes acidic heparin through ionic bonding. * **C. Alteplase:** This is a recombinant tissue plasminogen activator (rt-PA). It is a **fibrinolytic agent** itself, used to dissolve clots in MI or stroke, not an antidote. * **D. Dabigatran:** This is an **oral direct thrombin inhibitor (DTI)**. Its specific reversal agent (antidote) is **Idarucizumab**. **High-Yield Clinical Pearls for NEET-PG:** * **Antifibrinolytics:** EACA and Tranexamic acid are used in fibrinolytic overdose, post-prostatectomy bleeding, and heavy menstrual bleeding. * **Tranexamic acid** is roughly 10 times more potent than EACA. * **Specific Antidotes Summary:** * **Warfarin:** Vitamin K (slow), Fresh Frozen Plasma (rapid). * **Heparin:** Protamine Sulfate. * **Dabigatran:** Idarucizumab. * **Rivaroxaban/Apixaban:** Andexanet alfa. * **Fibrinolytics:** EACA or Tranexamic acid.

Q: Darbopoetin is most useful in the treatment of anemia caused by which of the following conditions?

Chronic renal failure. Darbepoetin alfa is a long-acting synthetic form of erythropoietin (EPO). The primary site of EPO production in the body is the peritubular interstitial cells of the kidney [1]. 1. Why Chronic Renal Failure (CRF) is correct: In CRF, the kidneys are unable to produce sufficient amounts of endogenous erythropoietin, leading to a normocytic, normochromic anemia [1]. Darbepoetin acts as an Erythropoiesis-Stimulating Agent (ESA), binding to the EPO receptor on erythroid progenitor cells in the bone marrow to stimulate red blood cell production. It is preferred over recombinant human erythropoietin (Epoetin) in clinical practice because it has a longer half-life (due to two additional N-linked oligosaccharide chains), allowing for less frequent dosing (weekly or bi-weekly). 2. Why other options are incorrect: * Iron Deficiency: This is a nutritional anemia caused by a lack of raw material (iron) for hemoglobin synthesis. The treatment is iron supplementation, not EPO stimulation. * Chemotherapy: While ESAs can be used in chemotherapy-induced anemia, they are strictly indicated only when the goal is palliative, as they may increase the risk of thromboembolism or tumor progression. CRF remains the primary and most definitive indication [1]. * Aplastic Anemia: This involves a primary bone marrow failure where the "factory" itself is damaged. Stimulating the marrow with EPO is generally ineffective; treatment involves immunosuppression or bone marrow transplant. High-Yield Clinical Pearls for NEET-PG: * Half-life: Darbepoetin alfa has a half-life ~3 times longer than Epoetin alfa. * Target Hemoglobin: In CRF patients, the target Hb should be maintained between 10–12 g/dL. Exceeding 13 g/dL increases the risk of stroke, hypertension, and cardiovascular events. * Pre-requisite: Always check Iron stores (Ferritin/TSAT) before starting Darbepoetin; it will not work if the patient is iron deficient.

Q: Low doses of aspirin prolong bleeding time by selectively inhibiting synthesis of the following mediator in the platelets?

Thromboxane A2. ### Explanation **Correct Option: A. Thromboxane A2 (TXA2)** Aspirin (Acetylsalicylic acid) acts by **irreversibly inhibiting the enzyme Cyclooxygenase-1 (COX-1)** via acetylation of a serine residue. In platelets, COX-1 is responsible for converting arachidonic acid into **Thromboxane A2 (TXA2)**, a potent vasoconstrictor and platelet aggregator. * **Mechanism of Selectivity:** Platelets are anuclear and cannot synthesize new enzymes. Therefore, a low dose of aspirin (75–150 mg) permanently disables COX-1 for the entire lifespan of the platelet (8–11 days), leading to a prolonged bleeding time. **Incorrect Options:** * **B. 5-Hydroxytryptamine (Serotonin):** While released from platelet dense granules during activation to promote aggregation, its synthesis is not the primary target of aspirin. * **C. Platelet Activating Factor (PAF):** This is a phospholipid mediator of inflammation and aggregation; its pathway is independent of the COX-1 enzyme inhibited by aspirin. * **D. Prostacyclin (PGI2):** PGI2 is a vasodilator and anti-aggregatory mediator produced by **vascular endothelial cells**. Unlike platelets, endothelial cells have nuclei and can regenerate COX enzymes. Low-dose aspirin spares PGI2 production while inhibiting TXA2, maintaining a favorable antithrombotic balance. **High-Yield Clinical Pearls for NEET-PG:** * **Irreversibility:** Aspirin is the only NSAID that binds irreversibly to COX. * **Bleeding Time (BT) vs. Clotting Time (CT):** Aspirin increases BT (platelet function) but has no effect on CT (coagulation cascade). * **Primary Prevention:** Low-dose aspirin is used for prophylaxis in Ischemic Heart Disease (IHD) and Stroke. * **Aspirin Resistance:** Can occur in patients with high platelet turnover.

Question 1

Urgent reversal of warfarin-induced bleeding can be achieved by the administration of which of the following?

Accepted Answer

Fresh frozen plasma

Answer

Cryoprecipitate

Answer

Platelet concentrates

Answer

Packed red blood cells

Question 2

What is the dose of vitamin K in cases of serious bleeding?

Accepted Answer

10 mg

Answer

2.5 mg

Answer

5 mg

Answer

20 mg

Question 3

All of the following are irreversible ADP inhibitors except?

Accepted Answer

Cangrelor

Answer

Ticlopidine

Answer

Clopidogrel

Answer

Prasugrel

Question 4

Epogen can be given in which of the following conditions?

Accepted Answer

Anemia of chronic renal failure

Answer

Aplastic anemia

Answer

Hemolytic anemia

Answer

Anemia of chronic disease

Question 5

Which of the following agents has demonstrated antithrombotic properties?

Accepted Answer

Dextran 40

Answer

Gelatin

Answer

Dextran 100

Answer

Hetastarch

Question 6

A 72-year-old woman with atrial fibrillation is on warfarin and is scheduled for ventral hernia repair. She was advised to stop warfarin several days before surgery and was hospitalized for heparinization. During her hospital stay, she developed severe abdominal and flank pain. Her prothrombin time (PT) is normal, but her activated partial thromboplastin time (aPTT) is elevated. An abdominal CT scan revealed a large retroperitoneal hematoma. Which of the following should be administered to reverse the effects of heparin?

Accepted Answer

Protamine sulfate

Answer

Thrombin

Answer

Vitamin K

Answer

Aprotinin

Question 7

Abciximab is:

Accepted Answer

Antibody against IIb/IIIa receptors

Answer

Antibody against Ib/IX receptors

Answer

Topoisomerase inhibitor

Answer

Adenosine inhibitor

Question 8

Which of the following substances can be used as an antidote to fibrinolytics?

Accepted Answer

Epsilon amino caproic acid

Answer

Protamine

Answer

Alteplase

Answer

Dabigatran

Question 9

Darbopoetin is most useful in the treatment of anemia caused by which of the following conditions?

Accepted Answer

Chronic renal failure

Answer

Iron deficiency

Answer

Chemotherapy

Answer

Aplastic anemia

Question 10

Low doses of aspirin prolong bleeding time by selectively inhibiting synthesis of the following mediator in the platelets?

Accepted Answer

Thromboxane A2

Answer

5-Hydroxytryptamine

Answer

Platelet activating factor

Answer

Prostacyclin

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?